Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness body scan may calm stress and inflammation after floods

NCT ID NCT07796919

Symptom relief Sponsor: Natalia Dewi Wardani, MD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests whether an 8-day mindfulness body scan can reduce stress, anxiety, and depression in adults who survived tidal flooding in Sayung, Demak, Indonesia. Participants will practice guided body scan meditation and have their blood tested for inflammation markers before and after. The study also checks sleep quality and resilience. If the practice helps, it could offer a simple way to support mental health after disasters.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mindfulness body scan, a guided 8-day behavioral practice focusing attention on different body regions to promote relaxation and reduce stress.
What this could lead to
If it works, this could offer a simple, low-cost way to ease stress, anxiety, and depression in people who have survived natural disasters, and possibly reduce related inflammation.
What could go wrong
The trial is small and short, with only 70 participants and an 8-day intervention. Results may not apply to other groups, and the effect on inflammation markers is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 60 years. * Survivors of tidal flooding (bencana rob) residing in the Sayung coastal area for at least 6 months. * Minimum educational attainment of Primary School (Sekolah Dasar / SD). * Literate in Indonesian (able to read and write). * Willing to participate in and complete the 8-day mindfulness intervention program. * Physically independent and capable of completing self-administered questionnaires. Exclusion Criteria: * Active psychotic disorders or severe mental illness. * Cognitive impairment that limits ability to complete assessments. * History of diagnosed autoimmune disorders, active allergies, or chronic inflammatory diseases. * Presence of acute infectious disease symptoms within the past 1 month. * Currently undergoing formal psychotherapy or other structured psychological interventions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression Inflammation inflammatory disease major depressive disorder post-traumatic stress disorder Stress, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Depression - major depressive disorder Inflammation Post-traumatic stress symptoms Psychological stress Survivor

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Puskesmas Sayung 1

    Demak, Central Java, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.